1
|
Cotte L, Hocqueloux L, Lefebvre M, Pradat P, Bani-Sadr F, Huleux T, Poizot-Martin I, Pugliese P, Rey D, Cabié A, Chirouze C, Drobacheff-Thiébaut C, Foltzer A, Bouiller K, Hustache-Mathieu L, Lepiller Q, Bozon F, Babre O, Brunel AS, Muret P, Chevalier E, Jacomet C, Laurichesse H, Lesens O, Vidal M, Mrozek N, Aumeran C, Baud O, Corbin V, Goncalvez E, Mirand A, brebion A, Henquell C, Lamaury I, Fabre I, Curlier E, Ouissa R, Herrmann-Storck C, Tressieres B, Receveur MC, Boulard F, Daniel C, Clavel C, Roger PM, Markowicz S, Chellum Rungen N, Merrien D, Perré P, Guimard T, Bollangier O, Leautez S, Morrier M, Laine L, Boucher D, Point P, Cotte L, Ader F, Becker A, Boibieux A, Brochier C, Brunel-Dalmas F, Cannesson O, Chiarello P, Chidiac C, Degroodt S, Ferry T, Godinot M, Livrozet JM, Makhloufi D, Miailhes P, Perpoint T, Perry M, Pouderoux C, Roux S, Triffault-Fillit C, Valour F, Charre C, Icard V, Tardy JC, Trabaud MA, Ravaux I, Ménard A, Belkhir AY, Colson P, Dhiver C, Madrid A, Martin-Degioanni M, Meddeb L, Mokhtari M, Motte A, Raoux A, Toméi C, Tissot-Dupont H, Poizot-Martin I, Brégigeon S, Zaegel-Faucher O, Obry-Roguet V, Laroche H, Orticoni M, Soavi MJ, Ressiot E, Ducassou MJ, Jaquet I, Galie S, Colson H, Ritleng AS, Ivanova A, Debreux C, Lions C, Rojas-Rojas T, Cabié A, Abel S, Bavay J, Bigeard B, Cabras O, Cuzin L, Dupin de Majoubert R, Fagour L, Guitteaud K, Marquise A, Najioullah F, Pierre-François S, Pasquier J, Richard P, Rome K, Turmel JM, Varache C, Atoui N, Bistoquet M, Delaporte E, Le Moing V, Makinson A, Meftah N, Merle de Boever C, Montes B, Montoya Ferrer A, Tuaillon E, Reynes J, Lefèvre B, Jeanmaire E, Hénard S, Frentiu E, Charmillon A, Legoff A, Tissot N, André M, Boyer L, Bouillon MP, Delestan M, Goehringer F, Bevilacqua S, Rabaud C, May T, Raffi F, Allavena C, Aubry O, Billaud E, Biron C, Bonnet B, Bouchez S, Boutoille D, Brunet-Cartier C, Deschanvres C, Gaborit BJ, Grégoire A, Grégoire M, Grossi O, Guéry R, Jovelin T, Lefebvre M, Le Turnier P, Lecomte R, Morineau P, Reliquet V, Sécher S, Cavellec M, Paredes E, Soria A, Ferré V, André-Garnier E, Rodallec A, Pugliese P, Breaud S, Ceppi C, Chirio D, Cua E, Dellamonica P, Demonchy E, De Monte A, Durant J, Etienne C, Ferrando S, Garraffo R, Michelangeli C, Mondain V, Naqvi A, Oran N, Perbost I, Carles M, Klotz C, Maka A, Pradier C, Prouvost-Keller B, Risso K, Rio V, Rosenthal E, Touitou I, Wehrlen-Pugliese S, Zouzou G, Hocqueloux L, Prazuck T, Gubavu C, Sève A, Giaché S, Rzepecki V, Colin M, Boulard C, Thomas G, Cheret A, Goujard C, Quertainmont Y, Teicher E, Lerolle N, Jaureguiberry S, Colarino R, Deradji O, Castro A, Barrail-Tran A, Yazdanpanah Y, Landman R, Joly V, Ghosn J, Rioux C, Lariven S, Gervais A, Lescure FX, Matheron S, Louni F, Julia Z, Le GAC S, Charpentier C, Descamps D, Peytavin G, Duvivier C, Aguilar C, Alby-Laurent F, Amazzough K, Benabdelmoumen G, Bossi P, Cessot G, Charlier C, Consigny PH, Jidar K, Lafont E, Lanternier F, Leporrier J, Lortholary O, Louisin C, Lourenco J, Parize P, Pilmis B, Rouzaud C, Touam F, Valantin MA, Tubiana R, Agher R, Seang S, Schneider L, PaLich R, Blanc C, Katlama C, Bani-Sadr F, Berger JL, N’Guyen Y, Lambert D, Kmiec I, Hentzien M, Brunet A, Romaru J, Marty H, Brodard V, Arvieux C, Tattevin P, Revest M, Souala F, Baldeyrou M, Patrat-Delon S, Chapplain JM, Benezit F, Dupont M, Poinot M, Maillard A, Pronier C, Lemaitre F, Morlat C, Poisson-Vannier M, Jovelin T, Sinteff JP, Gagneux-Brunon A, Botelho-Nevers E, Frésard A, Ronat V, Lucht F, Rey D, Fischer P, Partisani M, Cheneau C, Priester M, Mélounou C, Bernard-Henry C, de Mautort E, Fafi-Kremer S, Delobel P, Alvarez M, Biezunski N, Debard A, Delpierre C, Gaube G, Lansalot P, Lelièvre L, Marcel M, Martin-Blondel G, Piffaut M, Porte L, Saune K, Robineau O, Ajana F, Aïssi E, Alcaraz I, Alidjinou E, Baclet V, Bocket L, Boucher A, Digumber M, Huleux T, Lafon-Desmurs B, Meybeck A, Pradier M, Tetart M, Thill P, Viget N, Valette M. Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012–2018. Clin Infect Dis 2021; 73:e3266-e3274. [DOI: 10.1093/cid/ciaa1940] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2020] [Accepted: 01/01/2021] [Indexed: 01/15/2023] Open
Abstract
Abstract
Background
The arrival of highly effective, well-tolerated, direct-acting antiviral agents (DAA) led to a dramatic decrease in hepatitis C virus (HCV) prevalence. Human immunodeficiency virus (HIV)-HCV–coinfected patients are deemed a priority population for HCV elimination, while a rise in recently acquired HCV infections in men who have sex with men (MSM) has been described. We describe the variations in HIV-HCV epidemiology in the French Dat’AIDS cohort.
Methods
This was a retrospective analysis of a prospective cohort of persons living with HIV (PLWH) from 2012 to 2018. We determined HCV prevalence, HCV incidence, proportion of viremic patients, treatment uptake, and mortality rate in the full cohort and by HIV risk factors.
Results
From 2012 to 2018, 50 861 PLWH with a known HCV status were followed up. During the period, HCV prevalence decreased from 15.4% to 13.5%. HCV prevalence among new HIV cases increased from 1.9% to 3.5% in MSM but remained stable in other groups. Recently acquired HCV incidence increased from 0.36/100 person-years to 1.25/100 person-years in MSM. The proportion of viremic patients decreased from 67.0% to 8.9%. MSM became the first group of viremic patients in 2018 (37.9%). Recently acquired hepatitis represented 59.2% of viremic MSM in 2018. DAA treatment uptake increased from 11.4% to 61.5%. More treatments were initiated in MSM in 2018 (41.2%) than in intravenous drug users (35.6%). In MSM, treatment at the acute phase represented 30.0% of treatments in 2018.
Conclusions
A major shift in HCV epidemiology was observed in PLWH in France from 2012 to 2018, leading to a unique situation in which the major group of HCV transmission in 2018 was MSM.
Clinical Trials Registration. NCT02898987.
Collapse
Affiliation(s)
- Laurent Cotte
- Department of Infectious Diseases, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Lyon, France
| | - Laurent Hocqueloux
- Department of Infectious Diseases, Centre Hospitalier Régional d’Orléans – La Source, Orléans, France
| | - Maeva Lefebvre
- Department of Infectious Diseases, Centre Hospitalier Universitaire Hôtel-Dieu, Nantes; Centre d’Investigation Clinique (CIC) 1413, INSERM, Nantes, France
| | - Pierre Pradat
- Center for Clinical Research, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France
| | - Firouze Bani-Sadr
- Department of Internal Medicine, Clinical Immunology and Infectious Diseases, Robert Debré Hospital, University Hospital, Reims, France
| | - Thomas Huleux
- Department of Infectious Diseases and Travel Diseases, Centre Hospitalier Gustave-Dron, Tourcoing, France
| | - Isabelle Poizot-Martin
- Immuno-Hematology Clinic, Assistance Publique–Hôpitaux de Marseille, Hôpital Sainte-Marguerite, Marseille, Aix-MarseilleUniversity–Inserm–Institut de Recherche pour le Développement (IRD), Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale, Marseille, France
| | - Pascal Pugliese
- Department of Infectious Diseases, Centre Hospitalier Universitaire de Nice, Hôpital l’Archet, Nice, France
| | - David Rey
- HIV Infection Care Centre, Hôpitaux Universitaires, Strasbourg
| | - André Cabié
- Department of Infectious Diseases, Centre Hospitalier Universitaire de Martinique, Fort de France, Université des Antilles EA4537, Fort de France, INSERM CIC1424, Fort-de-France, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Lieutier-Colas F, Hasseine L, Machouart M, Vannini M, Emery S, Meyer F, Demoré B, Charmillon A, Simon L, Rabaud C. Fongémies à Candida spp : épidémiologie, sensibilité aux antifongiques et consommations d’antifongiques dans deux CHU français de 2015 à 2018. Med Mal Infect 2020. [DOI: 10.1016/j.medmal.2020.06.337] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
3
|
Dumartin C, Pefau M, Jouzeau A, Dugravot L, Rabaud C, Ali-Brandmeyer O, Reyreaud E, Rogues A, Lieutier-Colas F, Simon L. Consommations d’antibiotiques à large spectre par spécialités cliniques dans 1630 hôpitaux français en 2018. Med Mal Infect 2020. [DOI: 10.1016/j.medmal.2020.06.084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
4
|
Rabaud C, Goehringer F, Fall E, Peter L, Dufournaud M, Baux E, Balan M, Rotonda C, Machado J, Tarquinio C. Suspicion de maladie de Lyme : déterminants et conséquences psychologiques. Med Mal Infect 2020. [DOI: 10.1016/j.medmal.2020.06.359] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
5
|
Lieutier-Colas F, Jouzeau A, Dugravot L, Dumartin C, Martin C, Chabaud A, Charmillon A, Lefebvre N, Rabaud C, Simon L. Consommations d’antibiotiques anti-staphylococciques et résistance bactérienne dans les hôpitaux de la région Grand Est de 2014 à 2018 : la résistance est-elle le seul motif de la prescription ? Med Mal Infect 2020. [DOI: 10.1016/j.medmal.2020.06.085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
6
|
Caron F, Boutoille D, Faure K, Gazeau P, Leroy J, Rabaud C. Révision annoncée de l’instruction aux ARS sur la maîtrise de l’antibiorésistance : le regard des centres régionaux de conseils en antibiothérapie (CRCA). Med Mal Infect 2020. [DOI: 10.1016/j.medmal.2020.06.430] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
7
|
Couffignal C, Kolta S, Flamant M, Cazanave C, Haymann JP, Mentré F, Duval X, Leport C, Raffi F, Chêne G, Salamon R, Moatti JP, Pierret J, Spire B, Brun-Vézinet F, Fleury H, Masquelier B, Peytavin G, Garraffo R, Costagliola D, Dellamonica P, Katlama C, Meyer L, Salmon D, Sobel A, Cuzin L, Dupon M, Le Moing V, Marchou B, May T, Morlat P, Rabaud C, Waldner-Combernoux A, Hardel L, Reboud P, Couffin-Cadiergues S, Marchand L, Assuied A, Carrieri P, Habak S, Couturier F, Jadand C, Perrier A, Préau M, Protopopescu C, Schmit J, Chennebault J, Faller J, Magy-Bertrand N, Chirouze C, Humbert P, Longy-Boursier, Neau D, Granier P, Ansart S, Verdon R, Merrien D, Chevojon P, Sobel A, Levy Y, Piroth L, Perronne C, Froguel E, Ceccaldi J, Chidiac C, Grégoire V, Reynes J, Fuzibet JG, Arsac P, Bouvet E, Bricaire F, Monsonego J, Girard P, Guillevin L, Herson S, Molina J, Pialoux G, Sain O, Sellier P, Roblot F, Bani-Sadr F, Michelet C, Lucht F, Debord C, Martin T, De Jaureguiberry J, Bernard L. Nevirapine Use Is Associated with Higher Bone Mineral Density in HIV-1 Positive Subjects on Long-Term Antiretroviral Therapy. AIDS Res Hum Retroviruses 2020; 36:399-405. [PMID: 31891665 DOI: 10.1089/aid.2019.0229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
We assessed bone mineral density (BMD) in a cohort of human immunodeficiency virus (HIV)-positive patients after a median of 11 years of combination antiretroviral therapy (cART) and evaluated the respective role of HIV infection and antiretroviral drugs (ARVs). A cross-sectional study of 162 participants (131 male) from the ANRS-C08 cohort was performed with bone dual-energy X-ray absorptiometry (DXA) scans and renal assessment. The window of exposure to ARVs was defined as an exposure of more than six cumulative months during the last 3 years before the DXA evaluation to account for a cumulative exposure that could affect bone remodeling. The association with low BMD (Z-score < -2) was assessed by a multiple logistic regression model. The study population was 50 years (median), hepatitis C virus (HCV) (18%), and hepatitis B virus (HBV) (8%) coinfection with HIV-RNA <50 c/mL in 89%, median CD4 of 619/mm3. Prevalence of low BMD was 18% in males and 6% in females. The factors associated with a Z-score < -2 in males were uric acid renal loss [adjusted odds ratio (aOR): 6.1; 95% confidence interval (CI): 1.2-31.5; p = .03], HCV coinfection (aOR: 4.0; 95% CI: 1.3-12.2; p = .02), and less frequent window of exposure to nevirapine (NVP) (aOR: 0.1; 95% CI: 0.02-0.6; p = .01). For the full study sample, there was a strong positive association between duration of exposure to NVP and lumbar spine Z-score (p = .004). HIV-positive patients exposed to long-term cART have a high incidence of low BMD. Tenofovir disoproxil fumarate and ritonavir-boosted protease inhibitors did not seem to be associated with increased risk of low BMD, whereas NVP exposure appeared to have an independent positive association.
Collapse
Affiliation(s)
- Camille Couffignal
- Infection, Antimicrobials, Modeling, Evolution (IAME) UMR 1137, INSERM and Université of Paris, Paris, France
| | - Sami Kolta
- Department of Rheumatology, University Hospital Cochin, Assistance Publique–Hôpitaux de Paris, INSERM UMR-1153, Paris, France
| | - Martin Flamant
- Department of Physiology, University Hospital Bichat, Assistance Publique–Hôpitaux de Paris, Paris, France
| | - Charles Cazanave
- Infectious Diseases Department, University Hospital Bordeaux, Bordeaux, France
| | - Jean-Philippe Haymann
- Department of Physiology, University Hospital Tenon, and INSERM UMR_S1155, Paris, France
| | - France Mentré
- Infection, Antimicrobials, Modeling, Evolution (IAME) UMR 1137, INSERM and Université of Paris, Paris, France
| | - Xavier Duval
- Infection, Antimicrobials, Modeling, Evolution (IAME) UMR 1137, INSERM and Université of Paris, Paris, and INSERM CIC1425, Paris, France
| | - Catherine Leport
- Unité COREB (Coordination du Risque Epidémique et Biologique), Assistance Publique–Hôpitaux de Paris, Paris, France
| | - François Raffi
- Infectious Diseases Department, University Hospital Hotel-Dieu, and INSERM CIC 1413, University of Nantes, Nantes, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Gocko X, Lenormand C, Lemogne C, Bouiller K, Gehanno JF, Rabaud C, Perrot S, Eldin C, de Broucker T, Roblot F, Toubiana J, Sellal F, Vuillemet F, Sordet C, Fantin B, Lina G, Sobas C, Jaulhac B, Figoni J, Chirouze C, Hansmann Y, Hentgen V, Caumes E, Dieudonné M, Picone O, Bodaghi B, Gangneux JP, Degeilh B, Partouche H, Saunier A, Sotto A, Raffetin A, Monsuez JJ, Michel C, Boulanger N, Cathebras P, Tattevin P. Erratum à « Borréliose de Lyme et autres maladies vectorielles à tiques. Recommandations des sociétés savantes françaises » [Med. Mal. Infect. 49 (2019) 296–317]. Med Mal Infect 2019; 49:558-559. [DOI: 10.1016/j.medmal.2019.08.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
9
|
Gocko X, Lenormand C, Lemogne C, Bouiller K, Gehanno JF, Rabaud C, Perrot S, Eldin C, de Broucker T, Roblot F, Toubiana J, Sellal F, Vuillemet F, Sordet C, Fantin B, Lina G, Sobas C, Jaulhac B, Figoni J, Chirouze C, Hansmann Y, Hentgen V, Caumes E, Dieudonné M, Picone O, Bodaghi B, Gangneux JP, Degeilh B, Partouche H, Saunier A, Sotto A, Raffetin A, Monsuez JJ, Michel C, Boulanger N, Cathebras P, Tattevin P. Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies. Med Mal Infect 2019; 49:296-317. [PMID: 31257066 DOI: 10.1016/j.medmal.2019.05.006] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2019] [Accepted: 05/31/2019] [Indexed: 12/19/2022]
Affiliation(s)
- X Gocko
- Département de médecine générale, faculté de médecine, 42000 Saint-Étienne, France
| | - C Lenormand
- Dermatologie, hôpitaux universitaires de Strasbourg et faculté de médecine, université de Strasbourg, 67000 Strasbourg, France
| | - C Lemogne
- Psychiatrie, hôpital européen Georges-Pompidou, AP-HP.5, Inserm U1266, université Paris, 75015 Descartes, Paris, France
| | - K Bouiller
- Maladies infectieuses et tropicales, centre hospitalo-universitaire, UMR CNRS 6249 université Bourgogne Franche Comté, 25000 Besançon, France
| | - J-F Gehanno
- Médecine du travail, centre hospitalo-universitaire, 76000 Rouen, France
| | - C Rabaud
- Maladies infectieuses et tropicales, centre hospitalo-universitaire, 54100 Nancy, France
| | - S Perrot
- Centre d'étude et de traitement de la douleur, hôpital Cochin, 75014 Paris, France
| | - C Eldin
- Maladies infectieuses et tropicales, IHU Méditerranée infection, centre hospitalo-universitaire Timone, 13000 Marseille, France
| | - T de Broucker
- Neurologie, hôpital Delafontaine, 93200 Saint-DenisFrance
| | - F Roblot
- Inserm U1070, Maladies infectieuses et tropicales, centre hospitalo-universitaire, 86000 Poitiers, France
| | - J Toubiana
- Service de pédiatrie générale et maladies infectieuses, hôpital Necker-Enfants malades, AP-HP, 75014 Paris, France
| | - F Sellal
- Département de neurologie, hôpitaux Civil, 68000 Colmar, France
| | - F Vuillemet
- Département de neurologie, hôpitaux Civil, 68000 Colmar, France
| | - C Sordet
- Rhumatologie, centre hospitalo-universitaire, 67000 Strasbourg, France
| | - B Fantin
- Médecine interne, hôpital Beaujon, université Paris Diderot, Inserm UMR 1137 IAME, 92110 Clichy, France
| | - G Lina
- Laboratoire de bactériologie et CNR des Borrelia, faculté de médecine et centre hospitalo-universitaire, 67000 Strasbourg, France
| | - C Sobas
- Microbiologie, centre hospitalo-universitaire, 69000 Lyon, France
| | - B Jaulhac
- Laboratoire de bactériologie et CNR des Borrelia, faculté de médecine et centre hospitalo-universitaire, 67000 Strasbourg, France
| | - J Figoni
- Maladies infectieuses et tropicales, hôpital Avicenne, 930222 Bobigny, France; Santé publique France, 94410 St.-Maurice, France
| | - C Chirouze
- Maladies infectieuses et tropicales, centre hospitalo-universitaire, UMR CNRS 6249 université Bourgogne Franche Comté, 25000 Besançon, France
| | - Y Hansmann
- Maladies infectieuses et tropicales, centre hospitalo-universitaire, 67000 Strasbourg, France
| | - V Hentgen
- Pédiatrie, centre hospitalier, 78000 Versailles, France
| | - E Caumes
- Maladies infectieuses et tropicales, hôpital La Pitié-Salpêtrière, 75013 Paris, France
| | - M Dieudonné
- Centre Max-Weber, CNRS, université Lyon 2, 69000 Lyon, France
| | - O Picone
- Maternité Louis-Mourier, 92700 Colombes, France
| | - B Bodaghi
- Ophtalmologie, hôpital La Pitié-Salpêtrière, 75013 Paris, France
| | - J-P Gangneux
- Laboratoire de parasitologie-mycologie, UMR_S 1085 Irset, université Rennes1-Inserm-EHESP, centre hospitalo-universitaire, 35000 Rennes, France
| | - B Degeilh
- Laboratoire de parasitologie-mycologie, UMR_S 1085 Irset, université Rennes1-Inserm-EHESP, centre hospitalo-universitaire, 35000 Rennes, France
| | - H Partouche
- Cabinet de médecine générale, 93400 Saint-Ouen, département de médecine générale, faculté de médecine, université Paris Descartes, 75006 Paris, France
| | - A Saunier
- Médecine interne et maladies infectieuses, centre hospitalier, 24750 Périgueux, France
| | - A Sotto
- Maladies infectieuses et tropicales, centre hospitalo-universitaire, 30000 Nîmes, France
| | - A Raffetin
- Maladies infectieuses et tropicales, centre hospitalier intercommunal, 94190 Villeneuve-St-Georges, France
| | - J-J Monsuez
- Cardiologie, hôpital René-Muret, 93270 Sevran, France
| | - C Michel
- Médecine générale, 67000 Strasbourg, France
| | - N Boulanger
- Laboratoire de bactériologie et CNR des Borrelia, faculté de médecine et centre hospitalo-universitaire, 67000 Strasbourg, France
| | - P Cathebras
- Médecine interne, hôpital Nord, centre hospitalo-universitaire, 42000 Saint-Étienne, France
| | - P Tattevin
- Maladies infectieuses et reanimation médicale, hôpital Pontchaillou, centre hospitalo-universitaire, 35000 Rennes, France.
| | | |
Collapse
|
10
|
Abdo F, Marin E, Meyer F, Rabaud C, Pulcini C, May T, Demore B, Goehringer F. Pertinence de l’usage de la daptomycine dans un centre hospitalier universitaire : étude rétrospective monocentrique. Med Mal Infect 2019. [DOI: 10.1016/j.medmal.2019.04.153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
11
|
Jaulhac B, Saunier A, Caumes E, Bouiller K, Gehanno JF, Rabaud C, Perrot S, Eldin C, de Broucker T, Roblot F, Toubiana J, Sellal F, Vuillemet F, Sordet C, Fantin B, Lina G, Sobas C, Gocko X, Figoni J, Chirouze C, Hansmann Y, Hentgen V, Cathebras P, Dieudonné M, Picone O, Bodaghi B, Gangneux JP, Degeilh B, Partouche H, Lenormand C, Sotto A, Raffetin A, Monsuez JJ, Michel C, Boulanger N, Lemogne C, Tattevin P. Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies (II). Biological diagnosis, treatment, persistent symptoms after documented or suspected Lyme borreliosis. Med Mal Infect 2019; 49:335-346. [PMID: 31155367 DOI: 10.1016/j.medmal.2019.05.001] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2019] [Accepted: 05/07/2019] [Indexed: 11/18/2022]
Abstract
The serodiagnosis of Lyme borreliosis is based on a two-tier strategy: a screening test using an immunoenzymatic technique (ELISA), followed if positive by a confirmatory test with a western blot technique for its better specificity. Lyme serology has poor sensitivity (30-40%) for erythema migrans and should not be performed. The seroconversion occurs after approximately 6 weeks, with IgG detection (sensitivity and specificity both>90%). Serological follow-up is not recommended as therapeutic success is defined by clinical criteria only. For neuroborreliosis, it is recommended to simultaneously perform ELISA tests in samples of blood and cerebrospinal fluid to test for intrathecal synthesis of Lyme antibodies. Given the continuum between early localized and disseminated borreliosis, and the efficacy of doxycycline for the treatment of neuroborreliosis, doxycycline is preferred as the first-line regimen of erythema migrans (duration, 14 days; alternative: amoxicillin) and neuroborreliosis (duration, 14 days if early, 21 days if late; alternative: ceftriaxone). Treatment of articular manifestations of Lyme borreliosis is based on doxycycline, ceftriaxone, or amoxicillin for 28 days. Patients with persistent symptoms after appropriate treatment of Lyme borreliosis should not be prescribed repeated or prolonged antibacterial treatment. Some patients present with persistent and pleomorphic symptoms after documented or suspected Lyme borreliosis. Another condition is eventually diagnosed in 80% of them.
Collapse
Affiliation(s)
- B Jaulhac
- Laboratoire de bactériologie et cnr des Borrelia, faculté de médecine et centre hospitalo-universitaire, 67000 Strasbourg, France
| | - A Saunier
- Médecine interne et maladies infectieuses, centre hospitalier, 24750 Périgueux, France
| | - E Caumes
- Maladies infectieuses et tropicales, hôpital La Pitié-Salpêtrière, 75013 Paris, France
| | - K Bouiller
- Maladies infectieuses et tropicales, centre hospitalo-universitaire, UMR CNRS 6249 Université Bourgogne Franche Comté, 25000 Besançon, France
| | - J F Gehanno
- Médecine du travail, centre hospitalo-universitaire, 76000 Rouen, France
| | - C Rabaud
- Maladies infectieuses et tropicales, centre hospitalo-universitaire, 54100 Nancy, France
| | - S Perrot
- Centre d'étude et de traitement de la douleur, hôpital Cochin, 75014 Paris, France
| | - C Eldin
- Maladies infectieuses et tropicales, ihu méditerranée infection, centre hospitalo-universitaire Timone, 13000 Marseille, France
| | - T de Broucker
- Neurologie, hôpital Delafontaine, 92300 Saint-Denis, France
| | - F Roblot
- Maladies infectieuses et tropicales, centre hospitalo-universitaire, inserm U1070, 86000 Poitiers, France
| | - J Toubiana
- Service de pédiatrie générale et maladies infectieuses, hôpital Necker-Enfants Malades, AP-HP, 75014 Paris, France
| | - F Sellal
- Département de neurologie, hôpitaux civil, 68000 Colmar, France
| | - F Vuillemet
- Département de neurologie, hôpitaux civil, 68000 Colmar, France
| | - C Sordet
- Rhumatologie, centre hospitalo-universitaire, 67000 Strasbourg, France
| | - B Fantin
- Médecine interne, hôpital Beaujon, université Paris Diderot, Inserm UMR 1137 IAME, 92110 Clichy, France
| | - G Lina
- Microbiologie, centre hospitalo-universitaire, 69000 Lyon, France
| | - C Sobas
- Microbiologie, centre hospitalo-universitaire, 69000 Lyon, France
| | - X Gocko
- Département de médecine générale, faculté de médecine, 42000 Saint-Etienne, France
| | - J Figoni
- Maladies Infectieuses et tropicales, hôpital Avicenne, 93022 Bobigny, France; Santé publique France, 94410 St Maurice, France
| | - C Chirouze
- Maladies infectieuses et tropicales, centre hospitalo-universitaire, UMR CNRS 6249 Université Bourgogne Franche Comté, 25000 Besançon, France
| | - Y Hansmann
- Maladies infectieuses et tropicales, centre hospitalo-universitaire, 67000 Strasbourg, France
| | - V Hentgen
- Pédiatrie, centre hospitalier, 78000 Versailles, France
| | - P Cathebras
- Médecine interne, hôpital Nord, centre hospitalo-universitaire, 42000 Saint-Etienne, France
| | - M Dieudonné
- Centre Max Weber, CNRS, Université Lyon 2, 69000 Lyon, France
| | - O Picone
- Maternité Louis Mourier, 92700 Colombes, France
| | - B Bodaghi
- Ophtalmologie, hôpital La Pitié-Salpêtrière, 75013 Paris, France
| | - J P Gangneux
- Laboratoire de parasitologie-Mycologie, UMR_S 1085 Irset université Rennes1-Inserm-EHESP, centre hospitalo-universitaire, 35000 Rennes, France
| | - B Degeilh
- Laboratoire de parasitologie-Mycologie, UMR_S 1085 Irset université Rennes1-Inserm-EHESP, centre hospitalo-universitaire, 35000 Rennes, France
| | - H Partouche
- Cabinet de médecine générale, Saint-Ouen, département de médecine Générale, faculté de médecine. université Paris Descartes, 93400 Paris, France
| | - C Lenormand
- Dermatologie, hôpitaux universitaires de Strasbourg et faculté de médecine, université de Strasbourg, 67000 Strasbourg, France
| | - A Sotto
- Maladies infectieuses et tropicales, centre hospitalo-universitaire, 30000 Nîmes, France
| | - A Raffetin
- Maladies infectieuses et tropicales, centre hospitalier intercommunal, 94190 Villeneuve-St-Georges, France
| | - J J Monsuez
- Cardiologie, hôpital René Muret, 93270 Sevran, France
| | - C Michel
- Médecine générale, 67000 Strasbourg, France
| | - N Boulanger
- Médecine interne, hôpital Beaujon, université Paris Diderot, Inserm UMR 1137 IAME, 92110 Clichy, France
| | - C Lemogne
- Psychiatrie, hôpital européen Georges-Pompidou, AP-HP.5, Inserm U1266; Université Paris Descartes, 75015 Paris, France
| | - P Tattevin
- Maladies infectieuses et réanimation médicale, hôpital Pontchaillou, centre hospitalo-universitaire, 35033 Rennes, France.
| |
Collapse
|
12
|
Jacquet C, Lisowski C, Goehringer F, May T, Rabaud C. Prise en charge des patients « suspects » de Lyme par les médecins généralistes : difficultés rencontrées et propositions d’amélioration. Med Mal Infect 2018. [DOI: 10.1016/j.medmal.2018.04.278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
13
|
Coignard-Biehler H, Rapp C, Chapplain JM, Hoen B, Che D, Berthelot P, Cazenave-Roblot F, Rabaud C, Brouqui P, Leport C. The French Infectious Diseases Society's readiness and response to epidemic or biological risk-the current situation following the Middle East respiratory syndrome coronavirus and Ebola virus disease alerts. Med Mal Infect 2017; 48:95-102. [PMID: 29169817 PMCID: PMC7125712 DOI: 10.1016/j.medmal.2017.10.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2016] [Revised: 08/09/2017] [Accepted: 10/02/2017] [Indexed: 01/20/2023]
Abstract
CONTEXT In 2012, the French Infectious Diseases Society (French acronym SPILF) initiated the "Coordination of epidemic and biological risk" (SPILF-COREB - Emergences [SCE]) group to support the readiness and response of healthcare workers (HCWs) to new alerts. OBJECTIVE To present the SCE group, its functioning, and the main support it provided for frontline HCWs. METHODS A multidisciplinary group of heads of infectious disease departments from reference hospitals was created to build a network of clinical expertise for care, training, and research in the field of epidemic and biological risk (EBR). The network developed a set of standardized operational procedures (SOPs) to guide interventions to manage EBR-suspect patients. RESULTS A working group created the SOP aimed at frontline HCWs taking care of patients. Priority was given to the development of a generic procedure, which was then adapted according to the current alert. Five key steps were identified and hierarchized: detecting, protecting, caring for, alerting, and referring the EBR patient. The interaction between clinicians and those responsible for the protection of the community was crucial. The SOPs validated by the SPILF and its affiliates were disseminated to a wide range of key stakeholders through various media including workshops and the SPILF's website. CONCLUSION SPILF can easily adapt and timely mobilize the EBR expertise in case of an alert. The present work suggests that sharing and discussing this experience, initiated at the European level, can generate a new collective expertise and needs to be further developed and strengthened.
Collapse
Affiliation(s)
- H Coignard-Biehler
- Unité de coordination opérationnelle du risque épidémique et biologique, AP-HP, 75001 Paris, France; Service des maladies infectieuses et tropicales, hôpital Necker-Enfants malades, 75015 Paris, France; Samu 75, hôpital Necker-Enfants malades, 75015 Paris, France.
| | - C Rapp
- CMETE, 10, rue du Colonel-Driant, 75001 Paris, France; Hôpital d'instruction des armées Bégin, 69, avenue de Paris, 94160 Saint-Mandé cedex, France
| | - J M Chapplain
- Unité de coordination opérationnelle du risque épidémique et biologique, AP-HP, 75001 Paris, France; Service des maladies infectieuses et tropicales, hôpital Pontchaillou, 35000 Rennes, France
| | - B Hoen
- Inserm CIC 14-24, faculté de médecine Hyacinthe-Bastaraud, université des Antilles, centre hospitalier universitaire, 97110 Pointe-à-Pitre, Guadeloupe
| | - D Che
- Santé publique France, 94410 Saint-Maurice, France
| | - P Berthelot
- Unité d'hygiène interhospitalière, service des maladies infectieuses et laboratoire des agents infectieux et hygiène, CHU de Saint-Etienne, 42270 Saint-Priest-en-Jarez, France
| | - F Cazenave-Roblot
- Service des maladies infectieuses et tropicales, CHU de Poitiers, 86021 Poitiers, France
| | - C Rabaud
- Service des maladies infectieuses et tropicales, CHRU de Nancy, 54000 Nancy, France
| | - P Brouqui
- Service des maladies infectieuses et tropicales, hôpital Nord, 13000 Marseille, France
| | - C Leport
- Unité de coordination opérationnelle du risque épidémique et biologique, AP-HP, 75001 Paris, France; UMR 1137, Inserm, université Paris Diderot, 75018 Paris, France
| | | |
Collapse
|
14
|
Castan B, Lesprit P, Alfandari S, Bonnet E, Diamantis S, Gauzit R, Kerneis S, Leroy J, Lescure X, Meyssonnier V, Mondain V, Pavese P, Rabaud C, Stahl JP, Tattevin P, Roblot F, Pulcini C. [Antibiotic stewardship: A 2017 update]. Med Mal Infect 2017; 47:439-442. [PMID: 28781198 DOI: 10.1016/j.medmal.2017.06.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2017] [Accepted: 06/30/2017] [Indexed: 11/27/2022]
Affiliation(s)
- B Castan
- Unité fonctionnelle d'infectiologie régionale, CH Ajaccio, 20303 Ajaccio, France
| | - P Lesprit
- Infectiologie transversale, service de biologie clinique, hôpital Foch, 92151 Suresnes, France
| | - S Alfandari
- Service de réanimation et maladies infectieuses, CH de Tourcoing, 59200 Tourcoing, France
| | - E Bonnet
- Équipe mobile d'infectiologie, hôpital Joseph-Ducuing, 31300 Toulouse, France
| | - S Diamantis
- Service des maladies infectieuses et tropicales, CH Sud Île-de-France, 77011 Melun, France
| | - R Gauzit
- Équipe mobile d'infectiologie, AP-HP, hôpitaux universitaires Paris centre-site Cochin, université Paris Descartes, 75014 Paris, France
| | - S Kerneis
- Équipe mobile d'infectiologie, AP-HP, hôpitaux universitaires Paris centre-site Cochin, université Paris Descartes, 75014 Paris, France
| | - J Leroy
- ARLIN BFC/PRIMAIR, service d'hygiène hospitalière et service de maladies infectieuses, CHRU de Besançon, 25030 Besançon, France
| | - X Lescure
- IAME UMR 1137 Inserm, service de maladies infectieuses et tropicales, AP-HP, hôpital Bichat-Claude Bernard, faculté Paris Diderot, 75018 Paris, France
| | - V Meyssonnier
- CRIOAC, médecine interne, groupe hospitalier Diaconesses-Croix-Saint-Simon, 75020 Paris, France
| | - V Mondain
- Service des maladies infectieuses, CHU de Nice, Nice, France
| | - P Pavese
- Infectiologie, CHU, université Grenoble Alpes, 38700 Grenoble, France
| | - C Rabaud
- EA 4360 APEMAC, service de maladies infectieuses, CHRU de Nancy, université de Lorraine, 54000 Nancy, France
| | - J P Stahl
- Infectiologie, CHU, université Grenoble Alpes, 38700 Grenoble, France
| | - P Tattevin
- Maladies infectieuses et réanimation médicale, CHU de Rennes, hôpital Pontchaillou, 35033 Rennes, France
| | - F Roblot
- Service de médecine interne, maladies infectieuses et tropicales et Inserm U1070, CHU de Poitiers, 86021 Poitiers, France
| | - C Pulcini
- EA 4360 APEMAC, service de maladies infectieuses, CHRU de Nancy, université de Lorraine, 54000 Nancy, France.
| | | |
Collapse
|
15
|
Mailles A, Raguet S, Dupire A, Yai J, Malhere C, Jacquet S, Rabaud C. 2016 : un été au charbon. Med Mal Infect 2017. [DOI: 10.1016/j.medmal.2017.03.362] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
16
|
Perut V, Aumaître H, Pichard E, Patey O, Andre P, Welker Y, Bouchaud O, Rabaud C, Salmon Ceron D. Transversal infectious disease activity in French hospitals. Med Mal Infect 2017. [DOI: 10.1016/j.medmal.2016.09.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
17
|
Robert J, Péan Y, Alfandari S, Bru JP, Bedos JP, Rabaud C, Gauzit R. Application of guidelines for aminoglycosides use in French hospitals in 2013-2014. Eur J Clin Microbiol Infect Dis 2017; 36:1083-1090. [PMID: 28070748 DOI: 10.1007/s10096-016-2892-5] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2016] [Accepted: 12/27/2016] [Indexed: 10/20/2022]
Abstract
In 2011, the French Agency for Safety of Health Products issued guidelines underlining the principles of proper aminoglycosides' use. The aim of the survey was to evaluate adherence to these guidelines two years after their issue. Characteristics of patients receiving aminoglycosides were recorded by voluntary facilities during a 3-month survey in 2013-2014. The modalities of aminoglycosides treatment were analysed by comparison with the French guidelines. A total of 3,323 patients were included by 176 facilities. Patients were mainly hospitalized in medical wards (33.0%), and treated for urinary-tract infections (24.7%). Compliance regarding the clinical indication and the daily aminoglycosides dose was observed in 65.2% and 62.9% of the cases, respectively. A 30-min once-daily IV administration was recorded in 62.5% of the cases. Aminoglycosides treatment duration was appropriate (≤5 days) for 93.6% of the patients. When considering the four criteria together, 23.2% of the patients had a treatment regimen aligned with the guidelines. Requests for measurements of peak and trough AG serum concentrations matched the guidelines in 24.9% and 67.4% of the cases, respectively. Two years after guidelines issue, aminoglycosides use remains unsatisfactory in French health-care facilities. Efforts should be made for guidelines promotion, especially regarding the issue of underdosing.
Collapse
Affiliation(s)
- J Robert
- Centre d'Immunologie et des Maladies Infectieuses, CIMI, Team E13 (Bacteriology), Sorbonne Universités, UPMC Univ Paris 06, CR7, INSERM, U1135, 75013, Paris, France. .,AP-HP, Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Bacteriology and Hygiene, 75013, Paris, France. .,Laboratoire de Bactériologie-Hygiène, Faculté de Médecine Pierre et Marie Curie (UPMC Paris 6), 91 Boulevard de l'hôpital, 75634, Paris 13, France.
| | - Y Péan
- Observatoire National de l'Epidémiologie de la Résistance Bactérienne aux Antibiotiques (ONERBA), Paris, France
| | - S Alfandari
- Service de Réanimation et Maladies Infectieuses, CH Gustave Dron, Tourcoing, France
| | - J-P Bru
- Infectious Diseases Department, CH de la Région d'Annecy, Annecy, France
| | - J-P Bedos
- Intensive Care Unit, CH Henri Mignot de Versailles, Le Chesnay, France
| | - C Rabaud
- Infectious Diseases Department, CHU de Nancy, Nancy, France
| | - R Gauzit
- Intensive care Unit, CHU Cochin, APHP, Paris, France
| | | |
Collapse
|
18
|
Castan B, Lesprit P, Alfandari S, Bonnet E, Diamantis S, Gauzit R, Kernéis S, Leroy J, Lescure FX, Mondain V, Pavese P, Rabaud C, Stahl JP, Tattevin P, Roblot F, Pulcini C. [Antibiotic stewardship: What's new?]. Med Mal Infect 2016; 46:403-405. [PMID: 27856081 DOI: 10.1016/j.medmal.2016.11.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2016] [Accepted: 09/07/2016] [Indexed: 11/17/2022]
Affiliation(s)
- B Castan
- Unité fonctionnelle d'infectiologie régionale, centre hospitalier d'Ajaccio, 27, avenue Impératrice-Eugénie, 20303 Ajaccio, France
| | - P Lesprit
- Infectiologie transversale, service de biologie clinique, hôpital Foch, 40, rue Worth, 92151 Suresnes, France
| | - S Alfandari
- Service de réanimation et maladies infectieuses, centre hospitalier Tourcoing, 155, rue du Président-Coty, 59200 Tourcoing, France
| | - E Bonnet
- Équipe mobile d'infectiologie, hôpital Joseph-Ducuing, 15, rue Varsovie, 31300 Toulouse, France
| | - S Diamantis
- Service des maladies infectieuses, centre hospitalier de Melun, 2, rue Fréteau-de-Peny, 77011 Melun cedex, France
| | - R Gauzit
- Réanimation Ollier, CHU Cochin, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France
| | - S Kernéis
- Fédération d'infectiologie, université Paris Descartes, UMR 1181, Institut Pasteur, hôpital Cochin, AP-HP, 75014 Paris, France
| | - J Leroy
- PRIMAIR (Programme régional interdisciplinaire pour la maîtrise de la résistance aux anti-infectieux) ARLin B-FC, service d'hygiène hospitalière de maladies infectieuses, CHU de Besançon, 3, boulevard A.-Fleming, 25030 Besançon, France
| | - F X Lescure
- Service des maladies infectieuses et UMR 1137, Inserm, faculté de Paris Diderot, hôpital Bichat-Claude-Bernard, AP-HP, 5, rue Thomas-Mann, 75013 Paris, France
| | - V Mondain
- Infectiologie, hôpital de L'Archet, CHU de Nice, 4, avenue Reine-Victoria, 06003 Nice, France
| | - P Pavese
- Maladies infectieuses, CHU Grenoble-Alpes, boulevard de la Chantourne, 38700 La Tronche, France
| | - C Rabaud
- Fédération française d'infectiologie (CNP-FFI), 30, boulevard Pasteur, 75014 Paris, France
| | - J P Stahl
- Maladies infectieuses, CHU Grenoble-Alpes, boulevard de la Chantourne, 38700 La Tronche, France
| | - P Tattevin
- Maladies infectieuses et réanimation médicale, Inserm U 835, université Rennes-I, hôpital Pontchaillou, rue du Thabor, 35000 Rennes, France
| | - F Roblot
- Service de médecine interne et maladies infectieuses, Inserm U1070, CHU de Poitiers, 2, rue de la Milétrie, 86021 Poitiers, France
| | - C Pulcini
- Service de maladies infectieuses et Tropicales, université de Lorraine, EA 4360 APEMAC, hôpitaux de Brabois, CHRU de Nancy, 54511 Vandœuvre-Lès-Nancy cedex, France.
| |
Collapse
|
19
|
Hansmann Y, Chirouze C, Tattevin P, Alfandari S, Caumes E, Christmann D, Salomon J, Michelet C, Rabaud C, Roblot F. [Lyme disease: The French Infectious Diseases Society's statement]. Med Mal Infect 2016; 46:343-345. [PMID: 27592140 DOI: 10.1016/j.medmal.2016.08.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2016] [Accepted: 08/01/2016] [Indexed: 11/27/2022]
Affiliation(s)
- Y Hansmann
- Service des maladies infectieuses et tropicales NHC, CHU de Strasbourg, 1, place de l'Hôpital, 67091 Strasbourg, France
| | - C Chirouze
- Service des maladies infectieuses et tropicales, CHU de Besançon, hôpital Jean-Minjoz, 3, boulevard Fleming, 25030 Besançon cedex, France
| | - P Tattevin
- Service des maladies infectieuses et réanimation médicale, CHU de Rennes, hôpital Pontchaillou, 2, rue Henri-le-Guilloux, 35033 Rennes cedex 9, France
| | - S Alfandari
- Service de réanimation et maladies infectieuses, centre hospitalier de Tourcoing, BP 619, 155, rue du Président-Coty, 59208 Tourcoing cedex, France
| | - E Caumes
- Service d'infectiologie, CHU Pitié-Salpétrière, 47, boulevard de l'hôpital, 75013 Paris, France
| | - D Christmann
- Service des maladies infectieuses et tropicales NHC, CHU de Strasbourg, 1, place de l'Hôpital, 67091 Strasbourg, France
| | - J Salomon
- Hôpitaux universitaires Paris Île-de-France-Ouest, HUPIFO, AP-HP, 78000 Versailles, France
| | - C Michelet
- Service des maladies infectieuses et réanimation médicale, CHU de Rennes, hôpital Pontchaillou, 2, rue Henri-le-Guilloux, 35033 Rennes cedex 9, France
| | - C Rabaud
- Service des maladies infectieuses et tropicales, CHU de Nancy, 54500 Vandœuvre-lès-Nancy, France
| | - F Roblot
- Service de médecine interne, maladies infectieuses et tropicales, CHU de Poitiers, Inserm U1070, CHU la Miletrie, 2, rue de la Miletrie, 86021 Poitiers cedex, France.
| | | |
Collapse
|
20
|
Bourdellon L, Pulcini C, Fougnot S, May T, Rabaud C, Hénard S. COL 1-02 - Impact et acceptation de l’antibiogramme ciblé sur la prescription d’antibiotiques en médecine générale à l’échelle d’une région française. Med Mal Infect 2016. [DOI: 10.1016/s0399-077x(16)30257-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
21
|
Baux E, Aissa N, Pulcini C, May T, Lozniewski A, Rabaud C, Hénard S. BU-34 - Impact d’une antibiothérapie alternative aux carbapénèmes sur la mortalité dans le traitement des infections urinaires fébriles à eblse. Med Mal Infect 2016. [DOI: 10.1016/s0399-077x(16)30358-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
22
|
André M, Boyer L, Bevilacqua S, Frentiu E, Goehringer F, Hénard S, Jeanmaire E, Rabaud C, May T. VIH-23 - Bithérapies d’antirétroviraux chez des patients infectés par le VIH : efficacité et tolérance. Med Mal Infect 2016. [DOI: 10.1016/s0399-077x(16)30568-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
23
|
Fillion A, Ortega-Deballon P, Al-Samman S, Briault A, Brigand C, Deguelte S, Germain A, Hansmann Y, Pelascini E, Rabaud C, Chavanet P, Piroth L. Abdominal tuberculosis in a low prevalence country. Med Mal Infect 2016; 46:140-5. [PMID: 26995289 DOI: 10.1016/j.medmal.2016.02.003] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2015] [Revised: 01/12/2016] [Accepted: 02/16/2016] [Indexed: 12/23/2022]
Abstract
OBJECTIVE Abdominal tuberculosis is a rare disease. The clinical and radiological manifestations are non-specific and the diagnosis is difficult. Our objective was to describe the characteristics and treatment of patients presenting with abdominal tuberculosis in a low-incidence country. PATIENTS AND METHODS We reviewed the clinical, diagnostic, treatment, and outcome features of patients presenting with abdominal tuberculosis diagnosed by bacteriological and/or histological results and managed in five French university hospitals from January 2000 to December 2009. RESULTS We included 21 patients. The mean diagnostic delay was 13 months. Twelve patients (57%) came from a low-incidence area and only two had a known immunosuppressed condition. Eighteen patients (86%) presented with abdominal symptoms. The main organs involved were the peritoneum (n=14, 66%), the mesenteric lymph nodes (n=13, 62%), and the bowel (n=7, 33%). Sixteen patients (76%) underwent surgery, including two in an emergency setting. Seventeen patients (81%) received six months or more of anti-tuberculosis treatment. Finally, 16 patients (76%) had a positive outcome. CONCLUSION New diagnostic procedures, and especially molecular biology, may help diagnose unusual clinical presentations of tuberculosis. Invasive procedures are frequently necessary to obtain samples but also for the treatment of digestive involvement.
Collapse
Affiliation(s)
- A Fillion
- Infectious Diseases Department, University Hospital of Dijon, BP 97908, 21000 Dijon, France.
| | - P Ortega-Deballon
- Digestive and Surgical Oncology Department, University Hospital of Dijon, BP 97908, 21000 Dijon, France
| | - S Al-Samman
- Digestive and Surgical Oncology Department, University Hospital of Dijon, BP 97908, 21000 Dijon, France
| | - A Briault
- Department of Pneumology, University Hospital of Grenoble, CS 10217, 38043 Grenoble cedex 09, France
| | - C Brigand
- Department of Digestive Surgery, University Hospital of Strasbourg, 67098 Strasbourg, France
| | - S Deguelte
- Department of Digestive Surgery, University Hospital of Reims, Robert-Debré Hospital, avenue General-Koening, 51092 Reims cedex, France
| | - A Germain
- Department of Digestive, Hepatobiliary, and Endocrine Surgery, University Hospital of Nancy, Hôpitaux de Brabois, bâtiment Philippe-Canton, allée du Morvan, 54511 Vandœuvre-lès-Nancy cedex, France
| | - Y Hansmann
- Infectious Disease Department, University Hospital of Strasbourg, 1, place de l'Hôpital, 67091 Strasbourg cedex, France
| | - E Pelascini
- Department of Digestive Surgery, University Hospital of Lyon, Hôpital Édouard-Herriot, 5, place d'Arsonval, 69003 Lyon, France
| | - C Rabaud
- Infectious Diseases Department, University Hospital of Nancy, Hôpitaux de Brabois, bâtiment Philippe-Canton, allée du Morvan, 54511 Vandœuvre-lès-Nancy cedex, France
| | - P Chavanet
- Infectious Diseases Department, University Hospital of Dijon, BP 97908, 21000 Dijon, France
| | - L Piroth
- Infectious Diseases Department, University Hospital of Dijon, BP 97908, 21000 Dijon, France
| |
Collapse
|
24
|
Alfandari S, Robert J, Péan Y, Rabaud C, Bedos JP, Varon E, Lepape A, Bru JP, Gauzit R. Antibiotic use and good practice in 314 French hospitals: The 2010 SPA2 prevalence study. Med Mal Infect 2015; 45:475-80. [PMID: 26612602 DOI: 10.1016/j.medmal.2015.10.001] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2015] [Accepted: 10/01/2015] [Indexed: 11/15/2022]
Abstract
OBJECTIVES We aimed to assess antibiotic prescriptions to identify potential targets for improvement. METHODS We conducted a point prevalence survey (November 2010) of antibiotic use in 314 voluntary hospitals recruited by the French Infectious Diseases Society (SPILF) and the National Observatory for Epidemiology of Bacterial Resistance to Antimicrobials (ONERBA). Data were entered online, immediately analyzed and exported. RESULTS The prevalence of antibiotic use was 19.5% (9059/46,446patients). A higher prevalence was observed in the infectious disease (58.4%), hematology (58%), and intensive care (48.7%) units. The three most frequently used antibiotic classes were aminopenicillins (23.8%), fluoroquinolones (17.9%), and 3rd-generation cephalosporins (16.7%). A monotherapy was prescribed to 64% of patients. The reasons for the antibiotic prescription were written in the medical records of 74% of patients and 62% were consistent with the local guidelines. CONCLUSION Our results are similar to that of other studies. Various local targets for improvement have been identified to help hospitals define a better antibiotic stewardship.
Collapse
Affiliation(s)
- S Alfandari
- Service de réanimation et des maladies infectieuses, centre hospitalier Dron, 59208 Tourcoing, France.
| | - J Robert
- Bactériologie et hygiène, hôpitaux universitaires de la Pitié-Salpêtrière - Charles-Foix, AP-HP, 75013 Paris, France
| | - Y Péan
- Observatoire national de l'épidémiologie de la résistance bactérienne aux antibiotiques (ONERBA), 75006 Paris, France
| | - C Rabaud
- Service des maladies infectieuses, CHU, 54511 Nancy, France
| | - J P Bedos
- Service de réanimation, centre hospitalier Henri-Mignot, 78157 Le Chesnay, France
| | - E Varon
- Laboratoire de bactériologie, HEGP, 75908 Paris, France
| | - A Lepape
- Service de réanimation, hôpital Sud, 69495 Lyon, France
| | - J P Bru
- Service des maladies infectieuses, centre hospitalier de la région d'Annecy, 74374 Annecy, France
| | - R Gauzit
- Service d'anesthésie-réanimation chirurgicale, CHU Cochin, AP-HP, 75679 Paris, France
| | | |
Collapse
|
25
|
Weiss E, Zahar JR, Lesprit P, Ruppe E, Leone M, Chastre J, Lucet JC, Paugam-Burtz C, Brun-Buisson C, Timsit JF, Brun-Buisson C, Bruneel F, Chastre J, Lasocki S, Leone M, Montravers P, Nseir S, Paugam-Burtz C, Pease S, Timsit JF, Weiss E, Wolff M, Alfandari S, Fantin B, Gachot B, Lesprit P, Lucet JC, Potel G, Pulcini C, Rabaud C, Tattevin P, Armand-Lefevre L, Cavallo JD, Jarlier V, Joint-Lambert O, Robert J, Ruppé E, Woerther P. Corrigendum to ‘Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams’ [Clin Microbiol Infec 21 (2015) 649.e1–649.e10]. Clin Microbiol Infect 2015. [DOI: 10.1016/j.cmi.2015.07.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
26
|
Pulcini C, Alfandari S, Ballereau F, Bonnet E, Bruneel F, Castan B, Chidiac C, Cohen R, Descamps D, Doco-Lecompte T, Gauzit R, Guéry B, Jarlier V, Lesprit P, Marcelin AG, Molina JM, Rabaud C, Riché A, Salmon-Céron D, Senneville E, Stahl JP, Tattevin P, Varon E, Roblot F. [European Antibiotic Awareness Day: What is new in France?]. Med Mal Infect 2015; 45:345-7. [PMID: 26411783 DOI: 10.1016/j.medmal.2015.08.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2015] [Accepted: 08/03/2015] [Indexed: 11/24/2022]
Affiliation(s)
- C Pulcini
- Université de Lorraine, université Paris Descartes, EA 4360 APEMAC, France; Service de maladies infectieuses et tropicales, CHU de Nancy, Nancy, France.
| | | | | | - E Bonnet
- Hôpital Ducuing, Toulouse, France
| | - F Bruneel
- Service de réanimation, CH de Versailles, Le Chesnay, France
| | - B Castan
- Unité fonctionnelle d'infectiologie régionale, CH d'Ajaccio, Ajaccio, France
| | - C Chidiac
- Service de maladies infectieuses et tropicales, hôpital de la Croix Rousse, CHU de Lyon, Lyon, France
| | - R Cohen
- CH de Créteil, Créteil, France
| | - D Descamps
- Laboratoire de virologie, infections antimicrobials modelling evolution (IAME), Inserm UMR 1137, université Paris Diderot, Sorbonne Paris Cité, GH Bichat-Claude-Bernard, Paris, France
| | | | | | | | - V Jarlier
- CHU Pitié-Salpêtrière, Paris, France
| | - P Lesprit
- Hôpital Foch, infectiologie transversale, Suresnes, France
| | | | | | - C Rabaud
- Service de maladies infectieuses et tropicales, CHU de Nancy, Nancy, France
| | - A Riché
- CH de Angoulême, Angoulême, France
| | | | | | - J P Stahl
- CHU et université de Grenoble, Grenoble, France
| | | | - E Varon
- Hôpital européen Georges-Pompidou, Paris, France
| | - F Roblot
- CHU de Poitiers, Poitiers, France
| | | |
Collapse
|
27
|
Gaspard P, Ambert-Balay K, Mosnier A, Aho-Glélé S, Roth C, Larocca S, Simon L, Talon D, Rabaud C, Pothier P. Burden of gastroenteritis outbreaks: specific epidemiology in a cohort of institutions caring for dependent people. J Hosp Infect 2015; 91:19-27. [DOI: 10.1016/j.jhin.2015.05.012] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2015] [Accepted: 05/28/2015] [Indexed: 02/05/2023]
|
28
|
Weiss E, Zahar JR, Lesprit P, Ruppe E, Leone M, Chastre J, Lucet JC, Paugam-Burtz C, Brun-Buisson C, Timsit JF, Brun-Buisson C, Bruneel F, Chastre J, Lasocki S, Leone M, Montravers P, Nseir S, Paugam-Burtz C, Pease S, Timsit JF, Weiss E, Wolff M, Alfandari S, Fantin B, Gachot B, Lesprit P, Lucet JC, Potel G, Pulcini C, Rabaud C, Tattevin P, Armand-Lefevre L, Cavallo JD, Jarlier V, Joint-Lambert O, Robert J, Ruppé E, Woerther PL. Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams. Clin Microbiol Infect 2015; 21:649.e1-10. [DOI: 10.1016/j.cmi.2015.03.013] [Citation(s) in RCA: 76] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2014] [Revised: 01/05/2015] [Accepted: 03/05/2015] [Indexed: 01/22/2023]
|
29
|
Abdel Fattah M, Demoré B, Girardeau A, Heit S, May T, Rabaud C, Henard S. Antifungal agents use in a French administrative region. Med Mal Infect 2015; 45:279-85. [PMID: 26055629 DOI: 10.1016/j.medmal.2015.04.010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2014] [Revised: 03/27/2015] [Accepted: 04/30/2015] [Indexed: 11/17/2022]
Abstract
BACKGROUND The increased use of new costly antifungal agents has led to a considerable increase in pharmaceutical expenditure. In December 2011, the Lorraine Regional Health Agency commissioned the Antibiolor network to evaluate costly antifungal agent stewardship using as reference regional, French, and international recommendations. METHODS We performed a regional retrospective multicenter study. The criteria for evaluation were the appropriateness of the indication for treatment, the choice of the agent or of a combination, compliance with dose and treatment duration, and the absence of any alternative. RESULTS One hundred and fourteen prescriptions were analyzed, in 7 intensive care units, 4 hematology units, and 1 infectious diseases unit. The indication for costly antifungal treatment was appropriate in 110 cases (96.5%), the choice of the antifungal agent in 102 cases (93%), the dose in 98 cases (89%), treatment duration in 102 cases (93%), and an alternative antifungal treatment was possible in 10 cases (9%). Eighty-two prescriptions (74.5%) complied with the marketing authorization, 19 (17%) were related to a protocol for temporary use, and 9 (8%) were considered as inappropriate. CONCLUSION Our results show a high rate of appropriate prescriptions. The easily accessible and regularly updated local recommendations probably resulted in the standardization and optimization of costly antifungal agent prescriptions.
Collapse
Affiliation(s)
- M Abdel Fattah
- Service des maladies infectieuses et tropicales, hôpital Brabois, CHU de Nancy, allée du Morvan, 54500 Vandœuvre-lès-Nancy, France
| | - B Demoré
- Pharmacie hospitalière, CHU de Nancy, 54500 Vandœuvre-lès-Nancy, France; Réseau Antibiolor, CHU de Nancy, 54500 Vandœuvre-lès-Nancy, France; SRSMC, UMR 7565, université de Lorraine, 54001 Nancy, France
| | - A Girardeau
- Pharmacie hospitalière, CHU de Nancy, 54500 Vandœuvre-lès-Nancy, France
| | - S Heit
- Pharmacie hospitalière, CHU de Nancy, 54500 Vandœuvre-lès-Nancy, France
| | - T May
- Service des maladies infectieuses et tropicales, hôpital Brabois, CHU de Nancy, allée du Morvan, 54500 Vandœuvre-lès-Nancy, France; Réseau Antibiolor, CHU de Nancy, 54500 Vandœuvre-lès-Nancy, France
| | - C Rabaud
- Service des maladies infectieuses et tropicales, hôpital Brabois, CHU de Nancy, allée du Morvan, 54500 Vandœuvre-lès-Nancy, France; Réseau Antibiolor, CHU de Nancy, 54500 Vandœuvre-lès-Nancy, France
| | - S Henard
- Service des maladies infectieuses et tropicales, hôpital Brabois, CHU de Nancy, allée du Morvan, 54500 Vandœuvre-lès-Nancy, France; Réseau Antibiolor, CHU de Nancy, 54500 Vandœuvre-lès-Nancy, France.
| |
Collapse
|
30
|
Wang S, Pulcini C, Rabaud C, Boivin JM, Birgé J. Inventory of antibiotic stewardship programs in general practice in France and abroad. Med Mal Infect 2015; 45:111-23. [DOI: 10.1016/j.medmal.2015.01.011] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2014] [Revised: 12/18/2014] [Accepted: 01/28/2015] [Indexed: 12/18/2022]
|
31
|
Jeulin H, Foissac M, Boyer L, Agrinier N, Perrier P, Kennel A, Velay A, Goehringer F, Henard S, Rabaud C, May T, Schvoerer E. Real-life rilpivirine resistance and potential emergence of an E138A-positive HIV strain in north-eastern France. J Antimicrob Chemother 2014; 69:3095-102. [PMID: 25006240 DOI: 10.1093/jac/dku256] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
OBJECTIVES To assess the prevalence of resistance to rilpivirine and mutations at position 138 in reverse transcriptase and to identify associated epidemiological and biological characteristics. METHODS This retrospective study included 238 patients with available HIV-1 nucleotide sequences analysed at the Laboratory of Virology at the University Hospital of Nancy between January 2011 and June 2013. Resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) was evaluated according to the ANRS algorithm (version 23) and correlated with clinico-epidemiological and therapeutic data. The virus strains were analysed by evaluating the distance and distribution of the phylogenetic tree (MEGAv5). RESULTS Among previously treated patients (111/238, 46.6%), 68/111 (61.3%) had received NNRTIs; all were rilpivirine-naive. The prevalence of rilpivirine resistance in the whole cohort was 12.6% (30/238), and was 10.2% (13/127) and 15.3% (17/111) in naive and pre-treated patients, respectively. The E138A mutation was the most frequent mutation associated with resistance to rilpivirine (P < 0.0001). The prevalence of the E138A mutation tended to increase over time, from 3.6% (2/55) during the first half of 2011 to 9.3% (4/43) during the first half of 2013 (P = 0.0614). Seven viral strains from seven naive male patients positive for the E138A mutation appeared in the same cluster. CONCLUSIONS In our cohort of patients, we observed significantly increased resistance to rilpivirine, mostly because of the E138A mutation, probably due to an E138A strain circulating in newly diagnosed men who have sex with men. Taken together, our results emphasize the need to investigate the prevalence of rilpivirine resistance-associated mutations in the coming years both in France and abroad.
Collapse
Affiliation(s)
- H Jeulin
- CHU Nancy, Laboratoire de Virologie, Nancy, F-54000, France Université Lorraine, Faculté de Médecine, EA 7300, Vandoeuvre-les-Nancy, F-54500, France
| | - M Foissac
- CHU Nancy, Service de Maladies Infectieuses et Tropicales, Nancy, F-54000, France
| | - L Boyer
- CHU Nancy, Service de Maladies Infectieuses et Tropicales, Nancy, F-54000, France
| | - N Agrinier
- CHU Nancy, Service d'épidémiologie clinique, Nancy, F-54000, France
| | - P Perrier
- CHU Nancy, Laboratoire d'histocompatibilité, Nancy, F-54000, France
| | - A Kennel
- CHU Nancy, Laboratoire d'histocompatibilité, Nancy, F-54000, France
| | - A Velay
- CHU Nancy, Laboratoire de Virologie, Nancy, F-54000, France Université Lorraine, Faculté de Médecine, EA 7300, Vandoeuvre-les-Nancy, F-54500, France
| | - F Goehringer
- CHU Nancy, Service de Maladies Infectieuses et Tropicales, Nancy, F-54000, France
| | - S Henard
- CHU Nancy, Service de Maladies Infectieuses et Tropicales, Nancy, F-54000, France
| | - C Rabaud
- CHU Nancy, Service de Maladies Infectieuses et Tropicales, Nancy, F-54000, France
| | - T May
- CHU Nancy, Service de Maladies Infectieuses et Tropicales, Nancy, F-54000, France
| | - E Schvoerer
- CHU Nancy, Laboratoire de Virologie, Nancy, F-54000, France Université Lorraine, Faculté de Médecine, EA 7300, Vandoeuvre-les-Nancy, F-54500, France
| |
Collapse
|
32
|
Henard S, Boussat S, Demoré B, Clément S, Lecompte T, May T, Rabaud C. Comparison of hospital databases on antibiotic consumption in France, for a single management tool. Med Mal Infect 2014; 44:308-14. [DOI: 10.1016/j.medmal.2014.06.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2014] [Revised: 05/09/2014] [Accepted: 06/02/2014] [Indexed: 11/24/2022]
|
33
|
Boussat S, Clement S, Henard S, Rabaud S, Rabaud C. COL04-05 Retour sur l’utilisation pratique de l’outil ConsoRes – un plébiscite à 3 ans du début d’un déploiement progressif. Med Mal Infect 2014. [DOI: 10.1016/s0399-077x(14)70058-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
34
|
Hansmann Y, Leyer C, Lefebvre N, Revest M, Rabaud C, Alfandari S, Christmann D, Tattevin P. Feedback on difficulties raised by the interpretation of serological tests for the diagnosis of Lyme disease. Med Mal Infect 2014; 44:199-205. [PMID: 24794819 DOI: 10.1016/j.medmal.2014.03.009] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2013] [Revised: 01/15/2014] [Accepted: 03/26/2014] [Indexed: 11/17/2022]
Abstract
OBJECTIVES We had for objectives: i) to evaluate the accuracy of serologic testing for Lyme borreliosis performed in a private medical laboratory (PML); ii) to evaluate the impact of these tests on the practices of infectious diseases specialists (IDS). PATIENTS AND METHOD This study was performed in two steps: i) retrospective study of patients followed in a university hospital infectious diseases outpatient clinic for suspected Lyme borreliosis, tested (ELISA and Western blot) by both the PML and the National Reference Center (NRC); ii) national survey on IDS practices concerning patients consulting for suspected Lyme borreliosis. RESULTS Between July 2008 and July 2011, 128 patients consulting for suspected Lyme borreliosis were tested by both laboratories. Serological tests came back positive in 91% of cases from the PML versus 8% of cases from the NRC. Lyme borreliosis was the IDS's final diagnosis for 3.6% of patients. The survey on practices revealed that: i) the modal duration of consultation for suspected Lyme borreliosis was 30-60 minutes; ii) for 33% of patients, serologic test results performed at the PML were the only reason to suspect Lyme borreliosis; iii) 60% of patients had no indication for antibiotics. CONCLUSION The serological test performed in the PML were positive most of the time, but were not confirmed by tests performed at the NRC. This discrepancy lead to multiple and prolonged consultations in infectious diseases clinics, and discordance in the indications for antibiotics.
Collapse
Affiliation(s)
- Y Hansmann
- Service des maladies infectieuses et tropicales, hôpitaux universitaires de Strasbourg, 1, place de l'Hôpital, BP 426, 67091 Strasbourg cedex, France.
| | - C Leyer
- Service des maladies infectieuses et tropicales, hôpitaux universitaires de Strasbourg, 1, place de l'Hôpital, BP 426, 67091 Strasbourg cedex, France
| | - N Lefebvre
- Service des maladies infectieuses et tropicales, hôpitaux universitaires de Strasbourg, 1, place de l'Hôpital, BP 426, 67091 Strasbourg cedex, France
| | - M Revest
- Service des maladies infectieuses et réanimation médicale, université de Rennes-I, CHU Pontchaillou, 35033 Rennes cedex, France
| | - C Rabaud
- Service des maladies infectieuses et tropicales, hôpitaux de Brabois, CHU de Nancy, 54511 Vandœuvre-lès-Nancy cedex, France
| | - S Alfandari
- Service des maladies infectieuses et réanimation médicale, hôpital Gustave-Dron, CHRU de Lille, 59208 Tourcoing cedex, France
| | - D Christmann
- Service des maladies infectieuses et tropicales, hôpitaux universitaires de Strasbourg, 1, place de l'Hôpital, BP 426, 67091 Strasbourg cedex, France
| | - P Tattevin
- Service des maladies infectieuses et réanimation médicale, université de Rennes-I, CHU Pontchaillou, 35033 Rennes cedex, France
| |
Collapse
|
35
|
|
36
|
Rabaud C, Rogeaux O, Launay O, Strady C, Mann C, Chassany O, Bouhassira D, Gaillat J. Early antiviral treatment fails to completely prevent herpes-related pain. Med Mal Infect 2013; 43:461-6. [DOI: 10.1016/j.medmal.2013.07.012] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2013] [Revised: 07/17/2013] [Accepted: 07/25/2013] [Indexed: 11/16/2022]
|
37
|
Tattevin P, Cremieux AC, Rabaud C, Gauzit R. Efficacy and Quality of Antibacterial Generic Products Approved for Human Use: A Systematic Review. Clin Infect Dis 2013; 58:458-69. [DOI: 10.1093/cid/cit769] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
|
38
|
Bitar D, Caumes E, Chandre F, Del Guidice P, Gehanno JF, Le Goaster C, Monsel G, De Wazieres B, Rabaud C. [Management of one or several cases of scabies]. Arch Pediatr 2013; 20:1358-63. [PMID: 24183877 DOI: 10.1016/j.arcped.2013.09.027] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2013] [Revised: 08/26/2013] [Accepted: 09/26/2013] [Indexed: 11/27/2022]
Affiliation(s)
- D Bitar
- Institut de Veille Sanitaire, 12, rue du Val d'Osne, 94441 Saint-Maurice cedex, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Stahl JP, Salmon D, Bruneel F, Caumes E, Freymuth F, Bru JP, Morand P, Roblot F, Schmit JL, Strady C, Timsit JF, Rabaud C. Adult patients hospitalized for measles in France, in the 21st century. Med Mal Infect 2013; 43:410-6. [PMID: 24050842 DOI: 10.1016/j.medmal.2013.07.001] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2013] [Revised: 07/09/2013] [Accepted: 07/10/2013] [Indexed: 10/26/2022]
Abstract
BACKGROUND An epidemic of measles broke out in France in 2008. We designed a retrospective study focusing on adults hospitalized for measles in 2010/2011. METHODS A case was any patient aged more than 15 years, hospitalized (September 2010 to September 2011) with a typical rash or a biological diagnosis. Data was collected with standardized questionnaires in participating hospitals. RESULTS Four hundred and sixty cases were reported: sex-ratio (M/F) = 0.93, median age 26 years (σ = 8.8). Twenty-nine cases were severe (6.5%), 27 of which hospitalized in an ICU. Three hundred and twelve (68%) cases had elevated serum transaminases (EST), 155 (34%) cases had pneumonia, 34 (7%) cases had elevated serum creatinine (ESC), four (0.9%) cases had elevated serum amylase and lipase (ESAL), and three (0.7%) cases had neurological symptoms. One hundred and four (23%) patients presented simultaneously with EST and pneumonia. One patient presenting with severe pneumonia died (0.2%). One hundred and ten (24%) patients received antibiotics during a median seven days. CONCLUSION Measles can present as various syndromes in adults and be responsible for a high burden during outbreaks. The immediate outcome is favorable in most patients. Long-term outcome needs further investigations to identify possible late complications.
Collapse
Affiliation(s)
- J P Stahl
- Infectious Diseases, Joseph-Fourier University 1, CHU, 38043 Grenoble, France.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Rabaud C. [SPILF comments on procedures to be proposed in order to preserve antibiotics as priceless goods, and fight bacterial resistance spreading]. Med Mal Infect 2013; 43:97-9. [PMID: 23537745 DOI: 10.1016/j.medmal.2013.02.012] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2013] [Revised: 02/22/2013] [Accepted: 02/25/2013] [Indexed: 11/24/2022]
|
41
|
Rughoo L, Doco-Lecompte T, Henard S, Burty C, Desmots E, Letranchant L, Rabaud C, May T, Demoré B. Relevance of fluoroquinolone use in a French teaching hospital. Med Mal Infect 2012; 42:608-14. [DOI: 10.1016/j.medmal.2012.08.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2012] [Revised: 07/18/2012] [Accepted: 08/08/2012] [Indexed: 10/27/2022]
|
42
|
Boisseau D, Alfandari S, Gauzit R, Rabaud C, Stahl JP. Staphylococcus aureus nasal carriage during the infectious diseases national congress in France. Med Mal Infect 2012; 42:435-9. [PMID: 22959772 DOI: 10.1016/j.medmal.2012.07.014] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2012] [Revised: 04/11/2012] [Accepted: 07/24/2012] [Indexed: 11/27/2022]
Abstract
OBJECTIVE Screening for (methicillin-sensitive [MSSA] or -resistant [MRSA]) Staphylococcus aureus (SA) nasal carriage in health care workers in contact with fragile patients is a recurrent question. We wanted to assess carriage among infectious diseases healthcare workers. METHODS Voluntary health care workers were recruited during the 2010 Yearly French Congress (Journées Nationales d'Infectiologie, JNI). An anonymous double nasal swab was performed followed by PCR examination (GeneXpert MRSA/SA nasal tests) carried out on the Cepheid stand. Health care workers were also asked to fill in a questionnaire. Results were available 1 hour later but kept anonymous. RESULTS One hundred and fifty-two tests and questionnaires were selected. MRSA was isolated from four health care workers (2.4%). MSSA was isolated from 52 health care workers (34.2%). Sex, clinical activity of health care workers, hospital size, and systematic screening of patients did not affect carriage. CONCLUSIONS The prevalence of MSSA in nasal carriage in France is similar to the European one but the prevalence of MRSA is higher. This raises the question of a targeted decolonization in health care workers.
Collapse
|
43
|
May T, Burty C, Demoré B, Aissa N, Birgé J, Rabaud C, Doco-Lecompte T. Antibiolor, the Lorraine antibiology network: Update on 7 years of activity. Med Mal Infect 2012; 42:355-60. [DOI: 10.1016/j.medmal.2012.05.009] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2011] [Revised: 10/21/2011] [Accepted: 05/29/2012] [Indexed: 10/28/2022]
|
44
|
Ciotti C, Pellissier G, Rabaud C, Lucet JC, Abiteboul D, Bouvet E. Effectiveness of respirator masks for healthcare workers, in France. Med Mal Infect 2012; 42:264-9. [PMID: 22683102 DOI: 10.1016/j.medmal.2012.05.001] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2011] [Revised: 02/09/2012] [Accepted: 05/01/2012] [Indexed: 10/25/2022]
Abstract
OBJECTIVE The authors had for objective to evaluate the air-tightness of FFP2 respirator masks used by healthcare workers, with a quantitative fit-test protocol. MATERIALS AND METHODS This test measures the number of ambient particles inside and outside the respirator mask. The ratio between both is called fit-factor. The fit-test is successful for an FFP2 respirator mask when the fit-factor is equal or superior to 100. The tests were performed in three hospitals. Nine types of FFP2 respirator masks were fit-tested, classified in three groups: hard shell, duckbill, and flat-fold respirator masks. RESULTS One hundred and eighty fit-tests were performed. Less than a third of the fit-tests were successful (35/130). The rate of successful tests was higher with flat-fold (57.5%, 23/40) than with duckbill (18.3%, 11/60), or hard shell respirator masks (3.3%, 1/30), (P<0.05). Zero to 60% of healthcare workers had a successful fit-test with the respirator masks used in each hospital. This percentage increased with the number of tested respirator masks. No 100% success rate was ever reached in any hospital with the three tested respirator masks. CONCLUSION Duckbill, and flat-fold respirator masks seem to be better adapted for healthcare workers than hard shell respirator masks. It seems necessary to implement new recommendations for respiratory protection in France. At least two types of respirator masks with various sizes and shape should be available and fitting controls should be performed with respirator masks that are worn by healthcare workers exposed to infectious risks.
Collapse
Affiliation(s)
- C Ciotti
- Groupe d'Étude sur le Risque d'Exposition des Soignants aux Agents Infectieux-GERES, Faculté de Médecine Xavier-Bichat, 16 Rue Henri-Huchard, 75018 Paris, France.
| | | | | | | | | | | | | |
Collapse
|
45
|
Boussat S, Demoré B, Lozniewski A, Aissa N, Rabaud C. How to improve the collection and analysis of hospital antibiotic consumption: preliminary results of the ConsoRes software experimental implementation. Med Mal Infect 2012; 42:154-60. [PMID: 22424796 DOI: 10.1016/j.medmal.2012.02.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2011] [Revised: 12/05/2011] [Accepted: 02/09/2012] [Indexed: 10/28/2022]
Abstract
OBJECTIVE The online software ConsoRes is used to collect and analyze data on antibiotic consumption and evolution of bacterial resistance in healthcare institutions in every hospital ward (HW). We report the first results of ConsoRes implementation in the northeast hospitals of France. METHODOLOGY ConsoRes was implemented in January 2011, in nine volunteer hospitals after performing an onsite assessment. Five of these hospitals were already monitoring antibiotic consumption with a network such as Raisin ATB or Antibiolor, providing feedback on the various evaluation tools. RESULTS The ConsoRes data collection import function meets expectations of pharmacists, bacteriologists, or clinicians since it is user friendly, prevents redundant data input, and allows data transfer to the national databases. Importing the hospital organizational structure prevents mistakes on consumption allocation, which was noted in the previous databases, and makes comparison and benchmark analysis reliable. ConsoRes also provides a rapid consumption data feedback to all registered users within the hospital, whether in charge of a ward (clinician) or having a transversal function (pharmacist, bacteriologist). The availability of an automatic standard report or of an online customized report is another major feature of ConsoRes. CONCLUSION Besides providing surveillance, the concomitant analysis of local antibiotic consumption and bacterial resistance should have an educational impact by allowing each user to implement actions within the framework of antibiotic stewardship.
Collapse
Affiliation(s)
- S Boussat
- Centre de coordination de lutte contre les infections nosocomiales de l'Est, hôpitaux de Brabois, CHU de Nancy, rue du Morvan, Vandœuvre-lès-Nancy, France.
| | | | | | | | | |
Collapse
|
46
|
Bollaert M, Jeulin H, Waton J, Gastin I, Tréchot P, Rabaud C, Schmutz JL, Barbaud A. [Six cases of spring DRESS]. Ann Dermatol Venereol 2012; 139:15-22. [PMID: 22225738 DOI: 10.1016/j.annder.2011.10.397] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2011] [Revised: 08/12/2011] [Accepted: 10/26/2011] [Indexed: 11/30/2022]
Abstract
BACKGROUND An association between herpes virus reactivations and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) is accepted. We report six cases of DRESS with viral reactivation occurring within a single 1-month period. We attempted to find a common factor for these six cases and carried out clinical and virological examinations. Before and after this "epidemic", the mean number of cases of DRESS seen at the same centre was one per quarter, making the occurrence of six cases within a single month all the more remarkable and prompting us to seek an explanation. PATIENTS AND METHODS All six patients had taken a partly causative medication from different drug classes three to six weeks prior to the start of symptoms and herpes virus was detected in the blood of all of these subjects at the time of DRESS onset (four reactivations and two primary infections), and one patient subsequently displayed herpetic meningoencephalitis 95 days after the initial episode, associated with recurrence of DRESS. DISCUSSION There was no common denominator among these six DRESS patients in terms of either drug class or reactivation of a particular type of herpes virus, which raises the possibility of a single unidentified environmental agent. DRESS does not appear fully explainable in terms of a cellular response to drug antigens but seems rather to result from complex interactions between the drug-induced immune response, viral reactivation and antiviral immune response. Several investigators have reported sequential reactivation of herpes viruses in DRESS. A viral epidemic could thus cause a "DRESS epidemic" in patients on medication. CONCLUSION These cases point to the possible existence of a shared initial environmental factor (infectious or not) that favours reactivation of herpes viruses and induces DRESS in patients on medication. Before and after this "DRESS epidemic", about one patient each quarter was admitted to hospital for DRESS.
Collapse
Affiliation(s)
- M Bollaert
- Service de dermatologie, hôpitaux de Brabois, CHU de Nancy, bâtiment des spécialités médicales P.-Canton, Vandœuvre-lès-Nancy, France
| | | | | | | | | | | | | | | |
Collapse
|
47
|
Verjat-Trannoy D, Thillard D, Daniel F, Aupée M, Laland C, Simon L, Giard M, Rabaud C, Astagneau P. Assessment practices of peripheral venous catheters use: results of a multicentre observational study in France in 2010. BMC Proc 2011. [PMCID: PMC3239787 DOI: 10.1186/1753-6561-5-s6-p53] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
48
|
Aubert M, Aumaître H, Beytout J, Bloch K, Bouhour D, Callamand P, Chave C, Cheymol J, Combadière B, Dahlab A, Denis F, De Pontual L, Dodet B, Dommergues MA, Dufour V, Gagneur A, Gaillat J, Gaudelus J, Gavazzi G, Gillet Y, Gras-le-Guen C, Haas H, Hanslik T, Hau-Rainsard I, Larnaudie S, Launay O, Lorrot M, Loulergue P, Malvy D, Marchand S, Picherot G, Pinquier D, Pulcini C, Rabaud C, Regnier F, Reinert P, Sana C, Savagner C, Soubeyrand B, Stephan JL, Strady C. [Current events in vaccination]. Arch Pediatr 2011; 18:1234-46. [PMID: 22019286 DOI: 10.1016/j.arcped.2011.07.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
Abstract
The annual meeting of the Infectious Disease Society of America (IDSA) ; which brought together nearly 5000 participants from over 80 countries in Vancouver, Canada, October 21 to 24, 2010 ; provided a review of the influenza (H1N1) 2009 pandemic, evaluated vaccination programmes and presented new vaccines under development. With 12,500 deaths in the United States in 2009-2010, the influenza (H1N1) 2009 pandemic was actually less deadly than the seasonal flu. But it essentially hit the young, and the toll calculated in years of life lost is high. The monovalent vaccines, whether live attenuated or inactivated with or without adjuvants, were well tolerated in toddlers, children, adults and pregnant women. In order to protect infants against pertussis, family members are urged to get their booster shots. The introduction of the 13-valent Pneumococcal conjugated vaccine in the beginning of 2010 may solve - but for how long ? - the problem of serotype replacement, responsible for the re-increasing incidence of invasive Pneumococcal infections observed in countries that had introduced the 7-valent vaccine. The efficacy of a rotavirus vaccine has been confirmed, with a reduction in hospitalization in the United States and a reduction in gastroenteritis-related deaths in Mexico. In the United States, vaccination of pre-adolescents against human papillomavirus (HPV) has not resulted in any specific undesirable effects. Routine vaccination against chicken pox, recommended since 1995, has not had an impact on the evolution of the incidence of shingles. Vaccination against shingles, recommended in the United States for subjects 60 years and over, shows an effectiveness of 55 %, according to a cohort study (Kaiser Permanente, Southern California). Although some propose the development of personalized vaccines according to individual genetic characteristics, the priority remains with increasing vaccine coverage, not only in infants but also in adults and the elderly. Vaccine calendars that cover a whole lifetime should be promoted, since the vaccination of adults and seniors is a determining factor of good health at all ages.
Collapse
Affiliation(s)
- M Aubert
- Groupe Avancées Vaccinales, 69007 Lyon, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Bevilacqua S, Demoré B, Boschetti E, Doco-Lecompte T, May I, May T, Rabaud C, Thilly N. 15 years of antibiotic stewardship policy in the Nancy Teaching Hospital. Med Mal Infect 2011; 41:532-9. [PMID: 21907511 DOI: 10.1016/j.medmal.2011.08.001] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2011] [Revised: 03/04/2011] [Accepted: 08/03/2011] [Indexed: 11/15/2022]
Abstract
OBJECTIVES The authors report the results of a 15-year antibiotic stewardship policy in the Nancy Teaching Hospital and assess the impact of reinforcing this policy on antibiotic consumption. METHODS Antibiotic stewardship policy was initiated in the mid 90s and then reinforced from 2006 onwards. It was completed by prescription guidelines, nominative prescription of antibiotics, and an operational infectious diseases team (OIDT). The objectives were to promote antibiotic stewardship and decrease the use of extended broad spectrum or costly molecules and intravenous administration. Antibiotics consumption, as defined daily dose per 1000 patient days (DDD/1000PD) and in euros, was monitored from 2005 onwards. RESULTS Between 2005 and 2008, overall yearly cost of antibiotics dropped by 34% (-€1,308,902) and consumption in DDD/1000PD by 10%. This drop in consumption concerned all antibiotic classes. Teicoplanin prescription dropped by more than 50% and use of fluoroquinolone IV decreased by 15% in 3years. The operational team's interventions were effective since nearly 80% of suggested prescription amendments were accepted by prescribers. CONCLUSIONS This experiment shows that it is possible to implement antibiotic stewardship policy. Our results prove a significant decrease in overall consumption of antibiotic, a change in prescribing patterns, with a shift towards the use of cheaper antibiotics.
Collapse
Affiliation(s)
- S Bevilacqua
- Service des maladies infectieuses et tropicales, CHU Nancy, hôpitaux de Brabois, bâtiment P. Canton, rue du Morvan, Vandœuvre-Lès-Nancy, Nancy, France.
| | | | | | | | | | | | | | | |
Collapse
|
50
|
Gendrin V, Hénard S, Petitfrère M, May T, Rabaud C. [Effectiveness and risks related to enteric decolonization with oral streptomycin for glycopeptide-resistant enterocci carriers]. Med Mal Infect 2011; 41:563-4. [PMID: 21703786 DOI: 10.1016/j.medmal.2011.05.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2011] [Revised: 03/10/2011] [Accepted: 05/17/2011] [Indexed: 11/25/2022]
|